Inventor
Paul F. Fernandez
Inventor
Roseland, NJ, US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07BGeneral methods of organic chemistry27%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes9%
C07KPeptides9%
PatentTitleYear
10,513,519Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use201910,189,808Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses201910,047,090Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use2018Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2019Patents assigned to SIGNAL PHARM LLC (2)· patent assignee history
2018–2019Based in Roseland, NJ, US· patent location history
2019Patents assigned to CELGENE CORP (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGNAL PHARM LLC | 2 | 2018–2019 |
| CELGENE CORP | 1 | 2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Roseland, New Jersey, US | 3 | 2018–2019 |